• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1997 - 2021年意大利东北部新霉素致敏的患病率及影响因素

Prevalence and Determinants of Sensitisation to Neomycin in North-Eastern Italy, 1997-2021.

作者信息

Cegolon Luca, Larese Filon Francesca

机构信息

Department of Medical, Surgical & Health Sciences, University of Trieste, Trieste, Italy.

Public Health Department, University Health Agency Giuliano-Isontina (ASUGI), Trieste, Italy.

出版信息

Contact Dermatitis. 2025 Jun;92(6):460-468. doi: 10.1111/cod.14730. Epub 2025 Jan 8.

DOI:10.1111/cod.14730
PMID:39778913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12055313/
Abstract

BACKGROUND

Allergic contact dermatitis (ACD) induced by topical application of neomycin is frequently reported.

OBJECTIVES

This multi-center study investigated prevalence and determinants of neomycin sensitisations in 30 629 outpatients from North-eastern Italy during 1997-2021.

PATIENTS AND METHODS

European baseline and extended Triveneto series were applied on the upper back of patients patch testing for suspected ACD and removed after 48 h.

RESULTS

Prevalence of neomycin sensitisation was 2.29% (=701/30 629), significantly decreasing over time, especially after 2003. Neomycin sensitisation increased with age, especially in female patients older than 60 with leg dermatitis. The majority of patients sensitised to neomycin (74.5%) tested positive also against other haptens, particularly ingredients included in creams and emollients, as lanolin or benzocaine or preservatives as thimerosal or parabens.

CONCLUSIONS

The decreasing prevalence of neomycin sensitisation over time likely reflected reduced accessibility and circulation of neomycin in Italy, due to containment of prescriptions and over-the-counter accessibility. Older individuals are typically more likely to be treated by topical medications and antibiotics as neomycin for various conditions, including stasis dermatitis. Since ACD caused by topical medications is relatively easy to miss, comprehensive drug history and patch testing are essential for any patient with suspected sensitisation caused by neomycin.

摘要

背景

局部应用新霉素引起的过敏性接触性皮炎(ACD)屡有报道。

目的

这项多中心研究调查了1997年至2021年期间意大利东北部30629名门诊患者中新霉素致敏的患病率及决定因素。

患者与方法

将欧洲基线和扩展的的里雅斯特系列贴片应用于疑似ACD患者的上背部进行斑贴试验,48小时后移除。

结果

新霉素致敏的患病率为2.29%(=701/30629),随时间显著下降,尤其是在2003年之后。新霉素致敏率随年龄增加,尤其是60岁以上患有腿部皮炎的女性患者。大多数对新霉素致敏的患者(74.5%)对其他半抗原检测也呈阳性,特别是乳膏和润肤剂中的成分,如羊毛脂或苯佐卡因,或硫柳汞或对羟基苯甲酸酯等防腐剂。

结论

新霉素致敏患病率随时间下降可能反映了意大利新霉素的可及性和流通性降低,这是由于处方管控和非处方可及性受限。老年人通常更有可能因包括淤积性皮炎在内的各种病症而接受新霉素等局部用药和抗生素治疗。由于局部用药引起的ACD相对容易漏诊,对于任何疑似由新霉素引起致敏的患者,全面的用药史和斑贴试验至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af13/12055313/727016cb0a04/COD-92-460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af13/12055313/727016cb0a04/COD-92-460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af13/12055313/727016cb0a04/COD-92-460-g002.jpg

相似文献

1
Prevalence and Determinants of Sensitisation to Neomycin in North-Eastern Italy, 1997-2021.1997 - 2021年意大利东北部新霉素致敏的患病率及影响因素
Contact Dermatitis. 2025 Jun;92(6):460-468. doi: 10.1111/cod.14730. Epub 2025 Jan 8.
2
Frequency and trends of contact allergy to and iatrogenic contact dermatitis caused by topical drugs over a 25-year period.25年间外用药物引起的接触性过敏和医源性接触性皮炎的频率及趋势。
Contact Dermatitis. 2016 Nov;75(5):290-302. doi: 10.1111/cod.12621.
3
Contact allergy to neomycin sulfate: results of a multifactorial analysis.对硫酸新霉素的接触性过敏:多因素分析结果
Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):725-33. doi: 10.1002/pds.1117.
4
Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24-year study from Turkey.妥布霉素和抗青光眼药物成为局部眼用药物引起眶周过敏性接触性皮炎的主要元凶:来自土耳其的 24 年研究。
Contact Dermatitis. 2023 Jul;89(1):37-45. doi: 10.1111/cod.14309. Epub 2023 Mar 30.
5
Contact allergy to neomycin in consecutively patch tested Danish eczema patients from 2000 to 2023: A cross-sectional study.2000年至2023年连续进行斑贴试验的丹麦湿疹患者对新霉素的接触性过敏:一项横断面研究。
Contact Dermatitis. 2024 Nov;91(5):392-397. doi: 10.1111/cod.14653. Epub 2024 Jul 23.
6
Patch test results of the European baseline series among 1309 patients in Turkey between 2013 and 2019.2013 年至 2019 年期间,在土耳其的 1309 名患者中进行的欧洲基本系列斑贴试验结果。
Contact Dermatitis. 2021 Jan;84(1):15-23. doi: 10.1111/cod.13653. Epub 2020 Aug 3.
7
Should Paraben Mix Be Removed from The European Baseline Series.应从欧洲基本序列中去除对羟基苯甲酸酯混合物。
Acta Dermatovenerol Croat. 2021 Dec;29(3):171-172.
8
Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic.接触性皮炎的局部药物治疗:渥太华医院斑贴试验诊所的回顾性图表审查。
Dermatitis. 2012 Sep-Oct;23(5):210-3. doi: 10.1097/DER.0b013e31826e443c.
9
Comparative frequency of patch test reactions to topical antibiotics.局部用抗生素斑贴试验反应的比较频率
Br J Dermatol. 2002 Jun;146(6):1047-51. doi: 10.1046/j.1365-2133.2002.04662.x.
10
Contact sensitisation in adults: a 5-year retrospective review in hospital Kuala Lumpur.成人接触性致敏:吉隆坡医院的5年回顾性研究
Med J Malaysia. 2017 Apr;72(2):113-118.

引用本文的文献

1
A Multi-Center Study on Sensitization to Thimerosal in North-Eastern Italy, 1997-2023: Prevalence, Risk Factors, the Role of Occupation and the Impact of Vaccinations.1997 - 2023年意大利东北部硫柳汞致敏情况的多中心研究:患病率、风险因素、职业的作用及疫苗接种的影响
Vaccines (Basel). 2025 Jun 9;13(6):622. doi: 10.3390/vaccines13060622.
2
Epidemiological and Occupational Pattern of Patch-Test Reactions to p-Tert-butylphenol-formaldehyde Resin in North-Eastern Italy, 1997-2021.1997 - 2021年意大利东北部对对叔丁基苯酚甲醛树脂斑贴试验反应的流行病学和职业模式
Life (Basel). 2025 Apr 25;15(5):698. doi: 10.3390/life15050698.

本文引用的文献

1
Sensitization to Lanolin in North-Eastern Italy, 1997-2021: Prevalence, Risk Factors and the Impact of Occupation.1997 - 2021年意大利东北部对羊毛脂的致敏情况:患病率、风险因素及职业影响
Life (Basel). 2024 Jul 23;14(8):916. doi: 10.3390/life14080916.
2
Contact allergy to neomycin in consecutively patch tested Danish eczema patients from 2000 to 2023: A cross-sectional study.2000年至2023年连续进行斑贴试验的丹麦湿疹患者对新霉素的接触性过敏:一项横断面研究。
Contact Dermatitis. 2024 Nov;91(5):392-397. doi: 10.1111/cod.14653. Epub 2024 Jul 23.
3
Neomycin: sources of contact and sensitization evaluation in 1162 patients treated at a tertiary service.
新霉素:在一家三级医院治疗的 1162 名患者中接触和致敏评估的来源。
An Bras Dermatol. 2023 Jul-Aug;98(4):487-492. doi: 10.1016/j.abd.2022.07.008. Epub 2023 Mar 30.
4
Patch test results with the European baseline series, 2019/20-Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC.2019/20年欧洲基线系列斑贴试验结果——欧洲接触性皮炎学会(ESCD)的ESSCA和EBS工作组与西班牙皮肤病和性病学会(GEIDAC)的联合欧洲结果
Contact Dermatitis. 2022 Oct;87(4):343-355. doi: 10.1111/cod.14170. Epub 2022 Jun 24.
5
Contact Allergy in Canada Versus United States: Analysis of the North American Contact Dermatitis Group Data 2005-2016.加拿大与美国的接触性皮炎:2005-2016 年北美接触性皮炎组数据的分析。
Dermatitis. 2021;32(6):421-429. doi: 10.1097/DER.0000000000000701.
6
Approach to allergic contact dermatitis caused by topical medicaments.接触性药物性皮炎的处理方法。
Can Fam Physician. 2021 Jun;67(6):414-419. doi: 10.46747/cfp.6706414.
7
Systemic contact dermatitis following oral neomycin therapy.口服新霉素治疗后发生的系统性接触性皮炎。
Proc (Bayl Univ Med Cent). 2020 Aug 24;34(1):89-90. doi: 10.1080/08998280.2020.1805671.
8
Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018.2015-2018 年,ESSCA 网络中欧洲基础系列及附加系列的斑贴试验结果。
Contact Dermatitis. 2021 Feb;84(2):109-120. doi: 10.1111/cod.13704. Epub 2020 Oct 7.
9
Patch Testing Results From the Massachusetts General Hospital Contact Dermatitis Clinic, 2007-2016.2007-2016 年马萨诸塞州总医院接触性皮炎诊所的斑贴试验结果。
Dermatitis. 2020 May/Jun;31(3):202-208. doi: 10.1097/DER.0000000000000593.
10
Trends and current spectrum of contact allergy in Central Europe: results of the Information Network of Departments of Dermatology (IVDK) 2007-2018.中欧接触性过敏的趋势与当前谱:皮肤科部门信息网络(IVDK)2007 - 2018年的结果
Br J Dermatol. 2020 Nov;183(5):857-865. doi: 10.1111/bjd.18946. Epub 2020 Mar 29.